101 related articles for article (PubMed ID: 2552364)
1. 99Tcm-labelled meso-HMPAO and glutathione content of human lung tumours.
Rowell NP; McCready VR; Cronin B; Pepper J; Higley B; Burke JF; Tyrrell DA
Nucl Med Commun; 1989 Jul; 10(7):503-8. PubMed ID: 2552364
[TBL] [Abstract][Full Text] [Related]
2. Is 99Tcm hexamethyl-propyleneamine oxime uptake in the tissues related to glutathione cellular content?
el-Shirbiny AM; Sadek S; Owunwanne A; Yacoub T; Suresh L; Abdel-Dayem HM
Nucl Med Commun; 1989 Dec; 10(12):905-11. PubMed ID: 2622593
[TBL] [Abstract][Full Text] [Related]
3. 99Tcm-HMPAO brain SPECT in the evaluation of prognosis after surgical resection of astrocytoma. Comparison with other noninvasive imaging techniques (CT, MRI and 201Tl SPECT).
Rodrigues M; Fonseca AT; Salgado D; Vieira MR
Nucl Med Commun; 1993 Dec; 14(12):1050-60. PubMed ID: 8295760
[TBL] [Abstract][Full Text] [Related]
4. Assessment of antioxidative ability in brain: technetium-99m-meso-HMPAO as an imaging agent for glutathione localization.
Sasaki T; Toyama H; Oda K; Ogihara-Umeda I; Nishigori H; Senda M
J Nucl Med; 1996 Oct; 37(10):1698-701. PubMed ID: 8862315
[TBL] [Abstract][Full Text] [Related]
5. Technetium-99m-meso-HMPAO as a potential agent to image cerebral glutathione content.
Sasaki T; Senda M
J Nucl Med; 1997 Jul; 38(7):1125-9. PubMed ID: 9225804
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of primary lung carcinoma using technetium 99m-hexamethylpropylene amine oxime: preliminary clinical experience.
Oshima M; Itoh K; Okae S; Tadokoro M; Kodama Y; Sakuma S
Eur J Nucl Med; 1990; 16(12):859-64. PubMed ID: 2170143
[TBL] [Abstract][Full Text] [Related]
7. Investigations of brain tumours with 99Tcm-HMPAO SPECT.
Langen KJ; Roosen N; Herzog H; Kuwert T; Kiwit JC; Bock WJ; Feinendegen LE
Nucl Med Commun; 1989 May; 10(5):325-34. PubMed ID: 2787007
[TBL] [Abstract][Full Text] [Related]
8. Regional cerebral blood flow determined with single photon emission computed tomography and positron emission tomography. A comparative study.
Eriksson L; Larsson S; Bergstrand G; Roland P
Acta Radiol Suppl; 1986; 369():453-5. PubMed ID: 2980524
[TBL] [Abstract][Full Text] [Related]
9. Assessment of 99Tcm-HMPAO tumour scintigraphy using VX-2 tumours implanted in a lower limb muscle of rabbits.
Suga K; Honma Y; Uchisako H; Kuramitsu T; Tanaka N; Itou K; Ariyoshi I; Nakanishi T
Nucl Med Commun; 1991 Jul; 12(7):611-9. PubMed ID: 1923152
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of (99m)Tc-d,l-HMPAO for estimation of GSH content in tumor tissues.
Shimura N; Musya A; Hashimoto T; Kojima S; Kubodera A; Sasaki T
Nucl Med Biol; 2000 Aug; 27(6):577-80. PubMed ID: 11056372
[TBL] [Abstract][Full Text] [Related]
11. 99Tcm-HMPAO SPET and cerebral blood flow: a study of CO2 reactivity.
Choksey MS; Costa DC; Iannotti F; Ell PJ; Crockard HA
Nucl Med Commun; 1989 Aug; 10(8):609-18. PubMed ID: 2510102
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of glutathione localization in brain using 99mTc meso-HMPAO.
Sasaki T; Senda M
J Nucl Med; 1999 Jun; 40(6):1056-60. PubMed ID: 10452324
[TBL] [Abstract][Full Text] [Related]
13. Radiation effects on uptake of 99Tcm-hexamethylpropylen amine oxime (HMPAO) in head and neck tumours.
Minn H; Ahonen A; Paul R
Br J Cancer; 1991 Oct; 64(4):735-40. PubMed ID: 1911222
[TBL] [Abstract][Full Text] [Related]
14. Validation to eliminate vascular activity on 99Tcm-HMPAO brain SPECT for regional cerebral blood flow (rCBF) determination.
Hayashida K; Nishimura T; Imakita S; Uehara T
Nucl Med Commun; 1991 Jun; 12(6):545-50. PubMed ID: 1866107
[TBL] [Abstract][Full Text] [Related]
15. 99Tcm-HMPAO single photon emission computed tomography in partial epilepsy: a preliminary report.
Smith DF; Smith FW; Knight RS; Roberts RC; Gemmell HG
Br J Radiol; 1989 Nov; 62(743):970-3. PubMed ID: 2510899
[TBL] [Abstract][Full Text] [Related]
16. Oxido-reductive state: the major determinant for cellular retention of technetium-99m-HMPAO.
Jacquier-Sarlin MR; Polla BS; Slosman DO
J Nucl Med; 1996 Aug; 37(8):1413-6. PubMed ID: 8708786
[TBL] [Abstract][Full Text] [Related]
17. Distribution of glutathione and technetium-99m-meso-HMPAO in normal and diethyl maleate-treated mouse brain mitochondria.
Sasaki T; Fujibayashi Y; Senda M
J Nucl Med; 1998 Dec; 39(12):2178-83. PubMed ID: 9867165
[TBL] [Abstract][Full Text] [Related]
18. Quantitative single-photon emission tomography for tumour blood flow measurement in bronchial carcinoma.
Rowell NP; Flower MA; Cronin B; McCready VR
Eur J Nucl Med; 1993 Jul; 20(7):591-9. PubMed ID: 8370379
[TBL] [Abstract][Full Text] [Related]
19. Technetium-99m-d,1-hexamethylpropyleneamine oxime (HMPAO) uptake and glutathione content in brain tumors.
Suess E; Malessa S; Ungersböck K; Kitz P; Podreka I; Heimberger K; Hornykiewicz O; Deecke L
J Nucl Med; 1991 Sep; 32(9):1675-81. PubMed ID: 1880567
[TBL] [Abstract][Full Text] [Related]
20. Double-tracer SPECT in patients with AIDS encephalopathy: a comparison of 123I-IMP with 99Tcm-HMPAO.
Pohl P; Riccabona G; Hilty E; Deisenhammer F; Rösslér H; Zangerle R; Gerstenbrand F
Nucl Med Commun; 1992 Aug; 13(8):586-92. PubMed ID: 1513520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
